1. Wang, Xueyan, Yu, Jing, Liu, Xiaowei, Jing, Jing, Shi, Hubing. 2022. PSMG2-controlled proteasome-autophagy balance mediates the tolerance for MEK-targeted therapy in triple-negative breast cancer. In Cell reports. Medicine, 3, 100741. doi:10.1016/j.xcrm.2022.100741. https://pubmed.ncbi.nlm.nih.gov/36099919/
2. de Jesus, Adriana A, Brehm, Anja, VanTries, Rachel, Goldbach-Mansky, Raphaela, Krüger, Elke. 2019. Novel proteasome assembly chaperone mutations in PSMG2/PAC2 cause the autoinflammatory interferonopathy CANDLE/PRAAS4. In The Journal of allergy and clinical immunology, 143, 1939-1943.e8. doi:10.1016/j.jaci.2018.12.1012. https://pubmed.ncbi.nlm.nih.gov/30664889/
3. Zuidema, Dalen, Jones, Alexis, Song, Won-Hee, Zigo, Michal, Sutovsky, Peter. 2023. Identification of candidate mitochondrial inheritance determinants using the mammalian cell-free system. In eLife, 12, . doi:10.7554/eLife.85596. https://pubmed.ncbi.nlm.nih.gov/37470242/
4. Yin, Peng, Bai, Dazhang, Zhu, Longhong, Li, Shihua, Li, Xiao-Jiang. 2021. Cytoplasmic TDP-43 impairs the activity of the ubiquitin-proteasome system. In Experimental neurology, 345, 113833. doi:10.1016/j.expneurol.2021.113833. https://pubmed.ncbi.nlm.nih.gov/34363810/